"immune checkpoint inhibitor" trang 7 - tải miễn phí từ tailieunhanh
Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation

Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation
8    23    1
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer
12    35    1
Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-smallcell lung cancer patients: A retrospective multicenter study

Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-smallcell lung cancer patients: A retrospective multicenter study
11    30    1
A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers

A composite biomarker of neutrophillymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers
11    18    1
Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report

Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report
5    37    1
High incidence and early onset of nivolumab-induced pneumonitis: Four case reports and literature review

High incidence and early onset of nivolumab-induced pneumonitis: Four case reports and literature review
7    20    1
Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
13    48    1
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
11    37    1
Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis

Effcacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: A propensity-score-matched analysis
9    63    1
Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review
7    31    1
Landscape of homologous recombination deficiencies in solid tumours: Analyses of two independent genomic datasets

Landscape of homologous recombination deficiencies in solid tumours: Analyses of two independent genomic datasets
13    53    3
Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: A real-world, patient-level analysis

Modulation of chemoimmunotherapy efficacy in non-small cell lung cancer by sex and histology: A real-world, patient-level analysis
8    42    3
PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity

PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via enhancing c-Myc activity
24    52    1
Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy

Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy
16    46    1
A new risk model based on a 11-m6 A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

A new risk model based on a 11-m6 A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
11    20    1
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
8    16    1
Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis

Trends in treatment patterns and survival outcomes in advanced non-small cell lung cancer: A Canadian population-based real-world analysis
12    15    1
Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: A single center experience and literature review

Gestational trophoblastic neoplasia with extrauterine metastasis but lacked uterine primary lesions: A single center experience and literature review
11    20    1
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
10    16    1
Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: An open-label, single-arm, phase II trial

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: An open-label, single-arm, phase II trial
9    23    1